Jupiven Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.60 M
- Paid Up Capital ₹ 1.60 M
- Company Age 14 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.40 Cr
- Revenue Growth 61.21%
- Profit Growth 220.88%
- Ebitda 258.67%
- Net Worth 125.43%
- Total Assets 21.29%
About Jupiven Pharmaceuticals
Jupiven Pharmaceuticals Private Limited (JPPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 August 2010 and has a history of 14 years and six months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.60 M and a paid-up capital of Rs 1.60 M.
The company currently has active open charges totaling ₹1.40 Cr.
Sarojani Tiku, Subhash Tikoo, and Chitesh Tiku serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24232DL2010PTC206990
-
Company No.
206990
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Aug 2010
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Jupiven Pharmaceuticals Private Limited offer?
Jupiven Pharmaceuticals Private Limited offers a wide range of products and services, including Common Disease Medicines, Hair Growth Medicine, Cosmetics, Hair & Beauty Products, Skin Creams, Hair Care Cosmetics.
Who are the key members and board of directors at Jupiven Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sarojani Tiku
|
Director | 12-Aug-2010 | Current |
|
Subhash Tikoo
|
Director | 01-Aug-2013 | Current |
|
Chitesh Tiku
|
Director | 23-Jan-2022 | Current |
Financial Performance of Jupiven Pharmaceuticals.
Jupiven Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 61.21% increase. The company also saw a substantial improvement in profitability, with a 220.88% increase in profit. The company's net worth Soared by an impressive increase of 125.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jupiven Pharmaceuticals?
In 2021, Jupiven Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Saumor Skin Science LlpChitesh Tiku is a mutual person
Charges (Loans)
₹14.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 1.20 Cr
- Hdfc Bank Limited : 0.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Oct 2023 | Others | ₹7.00 M | Open |
| 01 Aug 2023 | Hdfc Bank Limited | ₹2.00 M | Open |
| 07 Dec 2021 | Others | ₹5.00 M | Open |
How Many Employees Work at Jupiven Pharmaceuticals?
Jupiven Pharmaceuticals has a workforce of 11 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jupiven Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jupiven Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
